Atsushi Kitamura
Osaka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Application of model-informed drug development (MIDD) for dose selection in regulatory submissions for drug approval in Japan.
Journal: Journal of pharmacokinetics and pharmacodynamics
Published: June 21, 2024
Association of xanthine oxidoreductase inhibitor use with insulin secretory capacity in patients with type 2 diabetes.
Journal: Journal of diabetes investigation
Published: April 11, 2024
Population pharmacokinetics of blonanserin in Japanese adolescent and adult patients with schizophrenia.
Journal: Drug metabolism and pharmacokinetics
Published: January 16, 2024
Pharmacokinetics and Safety of Imeglimin in Japanese Patients With Impaired Renal Function.
Journal: Journal of clinical pharmacology
Published: October 04, 2022
Naltrexone Transport by a Proton-Coupled Organic Cation Antiporter in hCMEC/D3 Cells, an in Vitro Human Blood-Brain Barrier Model.
Journal: Biological & pharmaceutical bulletin
Published: October 02, 2022
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy: Unique Characteristics of Blonanserin Transdermal Patch.
Journal: Journal of clinical psychopharmacology
Published: April 06, 2022
Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI-589 in Healthy Participants.
Journal: Clinical pharmacology in drug development
Published: January 12, 2022
Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes.
Journal: Clinical and translational science
Published: August 20, 2021
A novel phosphodiesterase 1 inhibitor reverses L-dopa-induced dyskinesia, but not motivation deficits, in monkeys.
Journal: Pharmacology, biochemistry, and behavior
Published: January 06, 2021
Pharmacokinetic Evaluation of Blonanserin Transdermal Patch: Population Analysis and Simulation of Plasma Concentration and Dopamine D2 Receptor Occupancy in Clinical Settings.
Journal: Journal of clinical pharmacology
Published: October 09, 2020
Structural Requirements for Uptake of Diphenhydramine Analogs into hCMEC/D3 Cells Via the Proton-Coupled Organic Cation Antiporter.
Journal: Journal of pharmaceutical sciences
Published: June 22, 2020
Prediction methods of drug-drug interactions of non-oral CYP3A4 substrates based on clinical interaction data after oral administrations - Validation with midazolam, alfentanil, and verapamil after intravenous administration and prediction for blonanserin transdermal patch.
Journal: Drug metabolism and pharmacokinetics
Published: December 08, 2019
Last Updated: 09/26/2026